Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mucosecretolytic-fluidizing and antibronchospastic activity, a process for its preparation and pharmaceutical compositions thereof

A novel theophylline-7- acetic acid ester is described. Said ester is obtained by reacting, at a temperature from 1 DEG to 20 DEG C., theophylline-7-acetic acid chloride with d,l-trans-sobrerol. There are further described pharmaceutical compositions with mucosecretolytic-fluidizing and antibronchos...

Full description

Saved in:
Bibliographic Details
Main Author MORA; CAMILLO C
Format Patent
LanguageEnglish
Published 24.03.1987
Edition4
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A novel theophylline-7- acetic acid ester is described. Said ester is obtained by reacting, at a temperature from 1 DEG to 20 DEG C., theophylline-7-acetic acid chloride with d,l-trans-sobrerol. There are further described pharmaceutical compositions with mucosecretolytic-fluidizing and antibronchospastic activity containing the novel ester.
Bibliography:Application Number: US19850711665